FDA 483 - SMS Lifesciences India Limited - May 09, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of SMS Lifesciences India Limited in Kazipally Village, India, revealed a significant deficiency in their microbial testing procedures for water used in manufacturing active pharmaceutical ingredients. The firm failed to ensure that test procedures were scientifically sound and appropriate, specifically regarding sample size and method suitability for water microbial limits. This indicates a serious concern regarding the quality control of critical manufacturing inputs.
ID · f0f0d971-944e-4201-9399-3fe733009808